Garralda E, Fiedler W, Matos I, Rolling C, et al. Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. Ann Oncol 2019;30 Suppl 4:iv125.
PMID: 32085014